tldrdailynews.com logo

Potential of GLP-1 Obesity Drugs in Treating Addiction and Alcohol Use Disorders

1 min read
Source: Nature
Potential of GLP-1 Obesity Drugs in Treating Addiction and Alcohol Use Disorders
Photo: Nature
TL;DR

Research suggests that blockbuster obesity drugs like semaglutide may have potential in treating addiction by acting on brain pathways related to reward and craving, with ongoing clinical trials exploring their efficacy for alcohol, nicotine, and opioid dependence, potentially revolutionizing addiction medicine.

Topics:health#addiction-treatment#drug-repurposing#glp-1#health#obesity-drugs#semaglutide
Share this article
  1. Will blockbuster obesity drugs revolutionize addiction treatment?  Nature
  2. GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders  Endocrine Society
  3. All the News That’s Fit: Obesity drugs’ alcohol effect, cheaper insulin and turkey eating  San Diego Union-Tribune
  4. GLP-1 Obesity Drugs Show Promise in Addiction Treatment  조선일보
  5. GLP-1s Hold Promise as Treatment for Alcohol Use Disorder  Gastroenterology Advisor

Want the full story? Read the original reporting

Read on Nature